Overview

Antibiotics and Hydroxychloroquine in Crohn's

Status:
Completed
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
There is growing evidence that Crohn's disease may be caused by replication of bacteria, perhaps particularly E. coli, within macrophages (a specialized sort of white blood cell). Laboratory studies show that a combination of antibiotics that can penetrate macrophages (such as ciprofloxacin and doxycycline) together with the anti-malarial drug hydroxychloroquine (which makes the contents of macrophage vesicles more alkaline and helps them to kill intracellular bacteria) is particularly effective at killing the E. coli within macrophages.
Phase:
Phase 2
Details
Lead Sponsor:
Royal Liverpool University Hospital
Collaborators:
National Association for Colitis and Crohn's Disease
National Institute for Health Research, United Kingdom
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Budesonide
Ciprofloxacin
Doxycycline
Hydroxychloroquine